Physician profile
Jonathan Burgei
NPI 1265936504
$1,885.55
in general payments reported to CMS, 2019-2025
9 companies · $92.53 in 2025
The $92.53 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $597 · 2023: $758 · 2024: $438 · 2025: $92.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,288.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $579.78 | 2022-2023 | Nucala |
| Grifols USA, LLC | $395.73 | 2022-2024 | Prolastin-C Liquid |
| Pulmonx Corporation | $376.10 | 2022-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Astrazeneca Pharmaceuticals LP | $149.34 | 2023-2024 | Breztri, Symbicort, Airsupra |
| Genzyme Corporation | $113.40 | 2023 | |
| Olympus America INC. | $109.04 | 2024-2025 | Single-Use Flexible Video Bronchoscope |
| Regeneron Healthcare Solutions, INC. | $99.90 | 2022 | |
| Boston Scientific Corporation | $36.31 | 2024 | General Pulmonary Endo |
| Pfizer INC. | $25.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Burgei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.